ReviewCancer drug resistance (Alhambra, Calif.)2025

The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy.

Meijiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.